Science and common sense show diverse animals are feeling beings who care about what happens to themselves and others, and ...

Some animals communicate at volumes that far exceed what humans can tolerate. From powerful vocal calls to thunderous natural ...

Most animal stories that make headlines are either funny or heartwarming, but the ones that stood out in 2025 were different.

But cleverness is hard to define - animals have to contend with different challenges in life and what might be clever or ...

The bioscience startup has attracted billions in investment – and a flurry of criticism, but founder tells the Guardian plans to bring back the woolly mammoth will not be derailed Death and taxes are ...

A little over a year after Colossal Biosciences launched its nonprofit arm with $50 million in funding, the Colossal Foundation has doubled its capital with another $50 million in fundraising. In the ...

Tom Brady says he has been given "a second chance" with a clone of his beloved family dog. The Fox Sports broadcaster and retired NFL legend revealed on Nov. 4 that his dog, Junie, is a clone of his ...

Colossal co-founder and CEO Ben Lamm (left) is interviewed by Bloomberg Texas bureau chief Julie Fine during a Venture Dallas session at the George W. Bush Presidential Center in University Park, ...

ViaGen has successfully cloned endangered species like Przewalski’s horses. Elizabeth Arellano Photography/Courtesy Colossal Biosciences However, Colossal CEO Ben Lamm insists the move wasn’t ...

This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris ...

Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and Equine, the global leader and expert in animal cloning. Viagen provides genetic preservation ...

After his company, Colossal Biosciences, successfully revived the dire wolf from extinction, he's ready to continue to change the world for the better, one cell at a time. By Carly Thomas Associate ...